Bio-Rad Laboratories
 
This week's BioPharma Dive brought to you by
 
 

Accurately detect seven critical ESR1 gene variants.
Explore the ESR1 Kit Now ▸

ddPLEX ESR1 Mutation Detection Kit
Bio-Rad ddPLEX ESR1 Mutation Detection Kit

Accelerate breast cancer research with Bio-Rad's ddPLEX ESR1 Mutation Detection Kit. This powerful kit enables researchers to accurately detect, discriminate, and quantify seven critical ESR1 gene variants.

Why this matters for your breast cancer research:

■ Ultra-sensitive detection down to 0.01% variant allele frequency (VAF)
■ Optimized for both plasma (cfDNA) and FFPE tissue samples
■ Cost-effective alternative to sequencing methods
■ Results delivered the same day with a streamlined workflow

Our ddPLEX technology, powered by Droplet Digital PCR (ddPCR), delivers the precision you need for superior ctDNA analysis and to better understand therapy resistance mechanisms in your breast cancer research.

For Research Use Only. Not for use in diagnostic procedures.

Trademarks | Privacy Policy | Copyright © 2025 Bio‑Rad Laboratories, Inc.
2000 Alfred Nobel Drive, Hercules, CA 94547, USA | 25-117055-EM-EN

 

Want to reach 108,000+ biopharma executives with your own message? Get the media kit or contact us directly at advertising@industrydive.com.

About this email: You are receiving this message as part of your complimentary newsletter subscription to BioPharma Dive. If you no longer wish to receive the daily newsletter, you can switch to a weekly subscription or unsubscribe. See our full privacy policy. BioPharma Dive is a product of TechTarget, Inc. and its subsidiaries, 275 Grove St. Newton, MA, 02466